INTRODUCTION
Prevalence studies are basic indicators for determining the quantity and impact of diseases among populations over previously established periods. 1, 2 They describe the number of people living with the disease of interest in a particular location or over a certain period. However, with regard to cancer, the definition of prevalence is unclear, since it is difficult to determine what is meant when it is said that an individual has been "cured". 3 Determination of the prevalence of a type of neoplasia is a useful tool for planning and administrating health services and programs. For example, the prevalence of the disease needs to be known when aiming to make a certain health service or product available to the population. 1, 3 Among the cancer prevalence rates relating to 25 different topographic sites, increasing breast cancer prevalence rates are being seen in various parts of the world. North America and Europe contribute the highest rates (125.9/100,000 and 106.2/100,000 respectively). 3 Other studies 2, [4] [5] [6] [7] [8] have also shown increased prevalence rates.
These increases have been correlated with higher incidence and longer survival 2, [7] [8] [9] and with population screening programs, thereby giving rise to higher case prevalence, especially of cases detected in the initial stages. 10 Such increases made breast cancer the malignant neoplasia of highest prevalence in the year 2002, with 17.9% of the cancer cases worldwide (4.4 million).
11
Although it is well established that early diagnosis and adequate treatment influence the mortality rates and prevalence of breast cancer, the amount of data available regarding such healthcare tools is small, both for Goiânia and for the whole of Brazil.
This makes it difficult to evaluate programs aimed at dealing with malignant breast neoplasms and, especially, makes it impossible to allocate financial and human resources according to the needs of each region.
OBJECTIVE
This study had the aim of analyzing the prevalence of breast cancer in Goiânia over a 15-year period.
METHODS
This was a retrospective population-based cross-sectional study on women with malignant breast neoplasms diagnosed in the city of Goiânia, state of Goiás, Brazil.
The cases were identified in the Goiânia Population-Based
Cancer Registry database (Registro de Câncer de Base Populacional de Goiânia, RCBP, Goiânia) and the data were gathered between 1988 and 2002.
The patients were followed up for five years from the date of diagnosis. In other words, patients diagnosed in 1988 were followed up until the end of 1992; patients diagnosed in 1989 were followed up until the end of 1993, and so on, until the year 2002.
The five-year prevalence was determined for each year of inci- The eligibility criteria for case inclusion followed the methodology used by RCBP in Goiânia, as previously described. [13] [14] [15] All the breast cancer cases diagnosed each year among women living in the municipality of Goiânia were eligible for inclusion. To avoid bias caused by women from other localities who went to Goiânia seeking treatment, the subjects included in this study needed to From the analysis according to five-year periods, it was seen that in the first five-year period, the rate was 19.39/100,000, and it was 44.79/100,000 in the last period. Over the fifteen years analyzed, the prevalence rate for breast cancer was 127.24/100,000 women (Figure 2) .
It was observed that with regard to the prevalence/incidence relationship, there was a significant increase in the prevalence in relation to incidence during the first five-year period, of 27.07%
per year (95% confidence interval, CI: 20.79-33.67; P < 0.001).
Subsequently, this growth fell to 9.39% (95% CI: 8.52-10.25; P < 0.001) per year during the second and third periods (1992) (1993) (1994) (1995) (1996) (1997) (1998) (1999) (2000) (2001) (2002) . Regarding incidence, the annual increase was 6.93% (95% CI: 5.5-8.3; P < 0.001) (Figure 3) .
Comparison between prevalence, incidence and mortality showed that the increase in prevalence was approximately three times greater than the increase in incidence, while the mortality remained stable over the course of these fifteen years, with a ratio of approximately 3.60 current cases for each incident case in each five-year period (Figure 4) .
DISCUSSION
Models for prevalence estimates are important for planning health programs and resource allocation according to each region's needs. This information is not always available to the bodies responsible for distributing the resources meant for health programs.
Up to a certain point, the breast cancer incidence rate reflects the social pattern, lifestyle, degree of information among the population, existence of screening programs and accessibility in each region. 8, 13, 14 Between 1988 and 2002, 2,906 new cases of this malignant type of neoplasia were gathered by RCBP in Goiânia. There was a greater increase from 1996 onwards, which coincided with the implementation of the "Viva Mulher" ("Long Live Women") breast and cervical cancer prevention programs 13, 14, 18 that were implemented by the Ministry of Health. Over the same period, 9,907 women were alive after the diagnosis, with a prevalence of 127/100,000.
The change from 27.07% to 9.39% annual growth in the prevalence observed over the first five years can be explained by the fact that we did not possess information on the preceding years.
Thus, when the evaluation was started in 1988, the prevalence was generated considering the incident cases of that year. For the subsequent years, we added together the new and old cases (excluding deaths), until the calculation was stabilized in 1992, at which Despite the Brazilian government's recommendation that mammography should be provided for women aged 40 years and over, the mammography coverage in the state of Goiás is approximately 46% for women in this age group. 19 Hence, it is far from the recommendation of 70%, which would be necessary for reducing the breast cancer mortality rate. 20 Therefore, one of the hypotheses raised to explain the increase in breast cancer incidence is that early diagnosis is now occurring, as has been observed in epidemiological studies on this type of neoplasia. 13, 14, 21 It can be asked whether this same hypothesis would explain the increase in prevalence observed in the present study, which grew from 22.87/100,000 women in 1988 to 220.22/100,000 women in 2002,
with an approximate increase of 197.35/100,000.
In Brazil, the lack of a national breast cancer screening program has led every city to develop its own separate strategies, with the intention of targeting specific populations (opportunistic screening). The main goal of breast cancer screening programs is to promote decreases in the mortality due to this type of neoplasia. 22 This has not been occurring, since the mortality due to breast cancer in Goiânia remained stable over the 15 years analyzed. 13 This is different from other countries such as the United
States, where the mortality rate has declined by 2.4% among white women and by 1.1% among Afro-American women. 23 Even so, we believe that mammographic screening has contributed towards early diagnosis, thus leading to an increased incidence rate 11, 24 and, consequently, detection of initial tumors.
This has increased survival and stimulated increased prevalence of breast cancer in Goiânia.
Another hypothesis that has been put forward to explain the increased prevalence observed in this study relates to the improvements in treatments. With the advent of new systemic therapies (multidrug therapy) and the development of hormone therapy for adjuvant treatment of breast cancer, changes to the prognostic profile for mortality and recurrence among patients have been obtained, which were only observed after a mean follow-up of 15 years. 25, 26 The neo and adjuvant treatments recommended by the guidelines 27, 28 for breast cancer have contributed towards increases in prevalence due to the increase in life expectancy among younger women and among women between 50 and 69 years of age. However, the same has not occurred for women over 70 years old. 26, [29] [30] [31] [32] The reasons for the increase in breast cancer prevalence in Goiânia are not well defined, because of difficulties in establishing the proportions of the contributions between mammographic screening and treatment. We believe that both favor increased survival and reduced mortality among women who have been diagnosed with breast cancer, which would lead to an increase in the prevalence rate.
This reasoning can be comprehended through the study by Berry et al., 33 who evaluated the reduction in mortality due to breast cancer by means of seven mathematical models. They concluded that both screening and treatment influenced the reduction in mortality, but they were unable to establish the significance of each of these actions separately, with regard to their impact on breast cancer mortality. 33 The prevalence rate in Goiânia over the 15-year period was 127/100,000 women. This rate is similar to what has been found by other authors 3, 11 who used the conventional model to estimate prevalence, with values of 125.9/100,000 and 106.2/100,000 in North America and Europe, respectively. 3 Diverging from previous data, other studies have shown higher prevalence rates in Europe, ranging from 300/100,000 to 1230/100,000. 2, [5] [6] [7] [8] The difference between these numbers and the previous ones possibly results from the methodology adopted for calculating the prevalence, since these studies used mathematical models that differed from those used by Pisani et al. 3 and Parkin et al. 11 The prevalence rate for breast cancer in the city of Goiânia increased significantly over the course of the study period. However, comparison of this rate with rates in other locations must be done with caution, since the methodology for calculating the prevalence rate differs considerably among the various studies on this topic.
Another hypothesis that may explain the differences between the rates is the socioeconomic situations of different countries, since it has been demonstrated that in developed countries, the breast cancer prevalence rate is higher than it is in developing countries. 5 Use of different periods and/or populations may have influenced the differences between prevalence rates among different authors. 2, [4] [5] [6] [7] [8] In the future, it is possible that there may be reductions in breast cancer prevalence in some parts of the world, due to greater primary prevention of breast cancer, including bilateral prophylactic mastectomy [34] [35] [36] and chemoprevention through the 
CONCLUSIONS
Thus, we conclude that the prevalence rate for breast cancer increased significantly in relation to the incidence rate, thereby demonstrating that opportunistic screening and improvements in diagnosis and treatment have been increasing life expectancy among women diagnosed with breast cancer in the city of Goiânia.
